Scaling and interpreting treatment effects in clinical trials using restricted mean survival time is a research paper published in Clinical Trials (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
national cancer institute
Grant: U.S. National Institutes of Health award U10 CA180
NCI NIH HHS
Grant: U10 CA180822
MeSH Terms
Keywords
sj-pdf-1-ctj-10.1177_17407745241254995 – Supplemental material for Scaling and interpreting treatment effects in clinical trials using restricted mean survival time
sj-pdf-1-ctj-10.1177_17407745241254995 – Supplemental material for Scaling and interpreting treatment effects in clinical trials using restricted mean survival time